Vimarsana
Biggest News Aggregation in the World

Page 7 - Immunity Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunity Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunity Unit Today - Breaking & Trending Today

21 April 2021 Coronavirus Charts and News: New coronavirus Variant Called BV-1 Found In Texas. Experts Increasingly Say Herd Immunity Is Not Possible. - Vimarsana News

21 April 2021 Coronavirus Charts and News: New coronavirus Variant Called BV-1 Found In Texas. Experts Increasingly Say Herd Immunity Is Not Possible.

The U.S. new cases 7-day rolling average are 9.4 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 26.9 % LOWER than the rolling average one week ago. Today's posts include: U.S. Coronavirus New Cases are 58,955 U.S. Coronavirus deaths are at 729 U.S. Coronavirus immunizations have been administered to 63.8 % of the population The 7-day rolling average rate of growth of the pandemic shows new cases improved and deaths improved The new coronavirus variants may put people who have been vaccinated at higher risk of a "breakthrough infection" The US ...

SARS-CoV-2: Infection induces antibodies capable of killing infected cells - Vimarsana News

SARS-CoV-2: Infection induces antibodies capable of killing infected cells

 E-Mail IMAGE: Antibodies kill infected cells by activating NK cells. In green, an infected cell, cultured in the presence of antibodies (invisible) and NK cells (white arrow). The NK cell comes into... view more  Credit: © Virus & Immunity Unit, Institut Pasteur Drawing on epidemiological field studies and the FrenchCOVID hospital cohort coordinated by Inserm, teams from the Institut Pasteur, the CNRS and the Vaccine Research Institute (VRI, Inserm/University Paris-Est Créteil) studied the antibodies induced in individuals with asymptomatic or symptomatic SARS-CoV-2 infection. Th...

US cardiologist makes false claims about Covid-19 vaccination - Vimarsana News

US cardiologist makes false claims about Covid-19 vaccination

Copyright AFP 2017-2021. All rights reserved. Video of a cardiologist claiming that there is no reason for healthy people under the age of 50 or those who have recovered from Covid-19 to be vaccinated against the virus has been viewed hundreds of thousands of times on social media. But medical experts say younger people should be inoculated because they can still be affected by the virus, and that the shots also benefit those who have already had the disease. “People under 50 who fundamentally have no health risks, there’s no scientific rationale for them to ever become vaccinated,” Dr ...

Source: afp.com
How this more contagious virus variant became dominant in the U.S. - Vimarsana News

How this more contagious virus variant became dominant in the U.S.

How this more contagious virus variant became dominant in the U.S. The B.1.1.7 strain is spreading among adults and kids, and experts say that's another reason to get vaccinated, fast. BySanjay Mishra Email The coronavirus variant known as B.1.1.7, which studies show is both more deadly and more transmissible than the original version of SARS-CoV-2, is now the most common strain circulating in United States, and its growing prevalence has alarmed prominent epidemiologists. Earlier in the pandemic, not many children were becoming infected with the coronavirus, and they did not appear to be maj...

Pfizer jab may not be as potent against B.1.351 variant - Vimarsana News

Pfizer jab may not be as potent against B.1.351 variant

Written by James Kingsland on April 1, 2021 — Fact checked by Rita Ponce, Ph.D. New research evaluates the effectiveness of the Pfizer vaccine against some of the new variants. Eric Thayer/Bloomberg via Getty Images Researchers tested the ability of antibodies in serum from vaccinated individuals and individuals who had previously contracted the virus to neutralize its B.1.1.7 and B.1.351 variants. The antibodies were as good at neutralizing the B.1.1.7 variant as they were at neutralizing an older variant. They were much less effective against the B.1.351 variant. The research suggests tha...